Indiana Life Sciences Capital: A Summary of 2019 Investments
An impressive $9.1 billion in capital was accessed by Indiana life sciences companies in 2019. The report details information on the types of funding, the companies who received capital, how much was funded, and the funders.
BioCrossroads advances Indiana’s signature strengths in the life sciences by connecting with corporate, academic and philanthropic partners; facilitating investments in promising start ups; building new enterprises; and educating through conferences, reports and market development knowledge.
NEWSLETTER SIGN UP
1210 Waterway Boulevard,
Indianapolis, IN 46202